Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 816 results for "eli lilly"

Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement
Sys-Con Media

UK Appeals Court Sides With Eli Lilly in Alimta Patent Case

The Court of Appeal in London has upheld Eli Lilly's vitamin regimen patent for its blockbuster cancer drug Alimta, blocking Actavis from marketing a generic version of the drug until 2021. Lilly's compound patent for Alimta (pemetrexed ... FDA News, 4 days ago

237 images for eli lilly

WKRB News, 2 days ago
WKRB News, 6 days ago, 2 days ago
ClinicSpace, 3 days ago
BioSpace, 6 days ago
Bidness Etc, 1 week ago
American Banking News, 1 week ago, 1 week ago, 1 week ago, 1 week ago

Piper Jaffray Reaffirms Overweight Rating for Eli Lilly and (LLY)

Piper Jaffray reissued their overweight rating on shares of Eli Lilly and (NYSE:LLY) in a research note released on Thursday morning, reports. They currently have a $102.00 target price on the stock, up from their previous ...
 WKRB News1 day ago AAIC Is Coming: Here's What To Expect, Biogen And Eli Lilly Investors  Benzinga.com2 days ago Eli Lilly In Retrospect: Shares Up 3.1% Since Upgraded One Week Ago (LLY)  Individual.com3 days ago Eli Lilly and Given Overweight Rating at Piper Jaffray (LLY)  SleekMoney3 days ago

Eli Lilly Rises 1.52% on Heavy Volume: Watch For Potential Pullback

Eli Lilly (NYSE:LLY) traded in a range yesterday that spanned from a low of $84.69 to a high of $86.24. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $85.58 on volume of 5.1 million shares. Often times ...
 Individual.com3 days ago SmarTrend Watching for Potential Pullback in Shares of Eli Lilly After 1.52% Gain  Individual.com3 days ago After Yesterday's Decline of 1.47%, Eli Lilly Offers Investors Better Value  Individual.com2 weeks ago Watch for Eli Lilly to Potentially Rebound After Falling 1.47% Yesterday  Individual.com2 weeks ago

Next Resistance Level for Eli Lilly (LLY) is $85.83

Shares of Eli Lilly (NYSE:LLY) have bullishly opened above the pivot of $84.47 today and have reached the first resistance level of $85.34. Investors may be interested in a cross of the next upside pivot targets of $85.83
 Individual.com3 days ago Eli Lilly (LLY) Approaches New Upside Target of $85.83  Individual.com3 days ago

Eli Lilly (LLY) Showing Resistance Near $86.21

MondayaEUR(TM)s trading in Eli Lilly and Co ("LLY) gives options traders an opportunity for a 12.57% return. By selling the Aug. '15 $85.00 call and buying the Jan. '17 call at the $55.00 level for a ...
 Individual.com5 days ago Eli Lilly (LLY) Trading Near $86.80 Resistance Level  Individual.com6 days ago Eli Lilly (LLY) Showing Bullish Technicals With Support At $82.64  Individual.com4 days ago Eli Lilly (LLY) Trading Near $82.48 Support Level  Individual.com1 week ago

Eli Lilly And (LLY) On Momo Momentum Watch Today

Reddit Email Reprint Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified Eli Lilly ...
 TheStreet.com3 days ago Eli Lilly And (LLY) Rising Before The Market Opens  TheStreet.com1 week ago

Eli Lilly Shares Up 14.0% Since SmarTrend's Buy Recommendation (LLY)

SmarTrend identified an Uptrend for Eli Lilly (NYSE:LLY) on May 22nd, 2015 at $74.10. In approximately 1 month, Eli Lilly has returned 13.98% as of today's recent price
 Individual.com4 days ago Eli Lilly Up 13.2% Since SmarTrend Uptrend Call (LLY)  Individual.com2 weeks ago

Potential Eli Lilly (LLY) Trade Has 3.65% Downside Protection

Eli Lilly and Co ("LLY) presents a trading opportunity that offers a 3.98% return in just 50 days. A covered call on Eli Lilly at the $85.00 level expiring on Aug. '15 offers an assigned return ...
 Individual.com3 days ago
Seeking Alpha

The Blockbuster Drug Cyramza May Not Be The Savior Eli Lilly Was Hoping For

Jul. 1, 2015 5:30 AM ET | About: Eli Lilly and Company (LLY) by: Summary Cyramza has received four FDA approvals creating a large base of potential customers. Cyramza faces stiff competition. Cyramza alone will not be able to return Eli ...
 Seeking Alpha4 days ago

Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Eli Lilly (LLY, BMY, MRK, SNY, AZN)

Written on Mon, 06/29/2015 - 9:35am By Amy Schwartz We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical ...
 Comtex SmarTrend6 days ago Eli Lilly is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (LLY, BMY, MRK, SNY, AZN)  Individual.com6 days ago Eli Lilly had the Lowest Relative Performance in the Pharmaceuticals Industry (LLY, PRGO, HSP, TEVA, NVS)  Individual.com2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - eli lilly
Get updated on latest news & your favorite topics right in your inbox!
More     Less